Adagene Inc.

Healthcare

NASDAQ:ADAG · NASDAQ Global Market

Market Cap $137.04M Beta 0.59 P/E (TTM) -7.7

$3.51 -0.28%

-$0.01 today

52W Low $1.30High $4.75

Vol 0.06M · Avg 0.22M

EPS (TTM) -$0.47Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+82.81%

Period High

$4.61

Period Low

$1.41

Latest

$3.51

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Fortress Biotech, Inc.

NASDAQ:FBIO

$92.02M

OS Therapies Incorporated

AMEX:OSTX

$75.71M

Adicet Bio, Inc.

NASDAQ:ACET

$75.25M

Gain Therapeutics, Inc.

NASDAQ:GANX

$71.66M

XBiotech Inc.

NASDAQ:XBIT

$71.34M

NRx Pharmaceuticals, Inc.

NASDAQ:NRXP

$66.38M

TScan Therapeutics, Inc.

NASDAQ:TCRX

$55.71M

Nutriband Inc.

NTRB

$41.21M

Lite Strategy, Inc.

LITS

$25.22M

CervoMed Inc.

CRVO

$22.68M

What is the latest ADAG filing?

The latest filing shown is SC 13D/A dated Jun 8, 2026.

How many recent filings does ADAG have?

Intrinsic Alpha currently shows 20 recent filings for ADAG.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.